Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks

Stock Track

Feb 20, 2025

Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.

Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.

Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1173135100"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173135100\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173135100?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 22:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173135100","market":"hk","top_or_hot":-1,"title":"Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks","media":"Stock Track","content":"<p>Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.</p>\n\n<p>Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Icon PLC Soars 5.98% as Analysts Maintain Buy Ratings and Optimistic Outlooks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-20 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.</p>\n\n<p>Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.</p>\n\n<p>Additionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICLR","symbol_name":"ICON plc","start_time":0,"source_url":"","article_id":"1173135100","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173135100","pubTimestamp":1740062356,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.Truist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ICLR":"ICON plc"},"translate_title":"分析师维持买入评级和乐观前景，股票赛道Icon PLC飙升5.98%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICLR":1},"content_text":"Shares of Icon PLC, a global provider of outsourced drug and device development and commercialization services, surged 5.98% in Thursday's pre-market trading session. The stock's rally comes after two analysts reiterated their Buy ratings on the company, citing positive outlooks.\nTruist Financial analyst Jailendra Singh maintained a Buy rating on Icon, highlighting the company's strong financial performance and growth prospects. Singh expressed optimism about Icon's ability to capitalize on the increasing demand for outsourced clinical research services.\nAdditionally, TD Cowen analyst Charles Rhyee maintained a Buy rating on Icon, with a price target of $254.00. Rhyee's report emphasized Icon's diversified service offerings and robust pipeline as key drivers for future growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}